TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

Stock analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the stock. TherapeuticsMD Stock Performance NASDAQ TXMD opened at $2.28 on Friday. The firm has a 50-day moving average of $2.39 and a 200-day moving average […]

Leave a Reply

Your email address will not be published.

Previous post German economy stalls – data
Next post HireRight (NYSE:HRT) Earns Hold Rating from Analysts at StockNews.com